Gestational

·MeSH: Diabetes, Gestational

4 drugs in development·4 companies·1 clinical trial

Drug Pipeline by Phase

Approved(2)

Drug	Company
neoprofen	Ultragenyx Pharmaceutical Inc. (RARE)
sivextro	Curative Biotechnology Inc (CUBT)

Phase 3(1)

Drug	Company
norditropin	Novo Nordisk A/S (NVO)

Phase 2/Phase 3(1)

Drug	Company
inhaled technosphere insulin	GH Research PLC (GHRS)

BioSniper tracks 4 drugs in development for Gestational across 4 companies.

There are 1 clinical trial targeting Gestational tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.